BEDY ETF Analysis: BNY Mellon Enhanced | NASDAQ
US Equity | NASDAQ, USA | Market Cap: 320m USD | 12M Return: 20.7% | US05613H3084 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 3.76M
Warnings
No concerns identified
Tailwinds
No distinct edge detected
Seasonality 0.9 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
BEDY is a dividend-focused ETF that invests at least 80% of its net assets in income-generating securities, including dividend-paying common stocks, convertible preferred stocks, equity-linked notes (ELNs), American Depositary Receipts (ADRs), and real estate investment trusts (REITs). The fund is classified within the Large Value category, meaning it generally targets large-capitalization U.S. equities trading at valuations considered below their fundamental measures. Stock selection is driven by a rules-based process that combines computer modeling, fundamental analysis, and risk management, managed by the funds adviser.
The underlying business model centers on income generation through a diversified mix of equity and equity-related instruments. Convertible preferred stocks offer fixed income with equity upside, while ELNs are structured debt instruments whose returns are linked to a specific equity. ADRs provide exposure to dividend-paying foreign companies trading on U.S. exchanges, and REITs are pass-through entities typically required to distribute the majority of their taxable income as dividends, making them a common holding in income-oriented portfolios.
- Fed rate cuts compress dividend yields across income securities
- Large-cap value stocks outperform amid growth-to-value rotation
- REIT income returns pressured by rising interest rate environment
As of November 01, 2026, the stock is trading at USD 29.66 with a total of 107,173 shares traded. Over the past week, the price has changed by +1.47%, over one month by +3.83%, over three months by +2.24% and over the past year by +20.69%.
Current recommended Stop Loss: 29.20 (which is 1.6% or 1.5 ATR below the current price).
BNY Mellon Enhanced has no consensus analysts rating.